Your browser doesn't support javascript.
loading
Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressiveness.
Lang, Robert; Rolny, Vinzent; Leinenbach, Andreas; Karl, Johann; Swiatek-de Lange, Magdalena; Kobold, Uwe; Schrader, Mark; Krause, Hans; Mueller, Markus; Vogeser, Michael.
Afiliação
  • Lang R; 1 Roche Diagnostics GmbH, Penzberg, Germany.
  • Rolny V; 1 Roche Diagnostics GmbH, Penzberg, Germany.
  • Leinenbach A; 1 Roche Diagnostics GmbH, Penzberg, Germany.
  • Karl J; 1 Roche Diagnostics GmbH, Penzberg, Germany.
  • Swiatek-de Lange M; 1 Roche Diagnostics GmbH, Penzberg, Germany.
  • Kobold U; 1 Roche Diagnostics GmbH, Penzberg, Germany.
  • Schrader M; 2 Helios Klinikum Berlin-Buch, Berlin, Germany.
  • Krause H; 3 Urologische Klinik, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Mueller M; 4 Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Ludwigshafen, Germany.
  • Vogeser M; 5 Institute of Laboratory Medicine, Hospital of the Ludwig-Maximilians University, Munich, Germany.
Tumour Biol ; 41(3): 1010428319827223, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30907281
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Neoplasias da Próstata / Biomarcadores Tumorais / Antígeno Prostático Específico Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Neoplasias da Próstata / Biomarcadores Tumorais / Antígeno Prostático Específico Idioma: En Ano de publicação: 2019 Tipo de documento: Article